Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-20 08:00 am Purchase | 13G | SURFACE ONCOLOGY INC SURF | ADAR1 Partners LP | 3,183,242 5.24% | 3,183,242 (New Position) | View |
| 2023-02-13 2:08 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 3,924,713 6.5% | -728,287 (-15.65%) | View |
| 2023-02-10 2:08 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | ARK Investment Management LLC | 5,567,224 9.2% | -756,309 (-11.96%) | View |
| 2023-01-31 08:57 am Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 2,945,453 4.87% | 0 (Unchanged) | View |
| 2022-08-09 09:46 am Purchase | 13G | SURFACE ONCOLOGY INC SURF | ARK Investment Management LLC | 6,323,533 11.58% | 997,406 (+18.73%) | View |
| 2022-05-09 3:12 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | BlackRock Inc. BLK | 2,502,271 4.6% | -60,414 (-2.36%) | View |
| 2022-03-14 3:55 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 4,653,000 9.9% | 4,604,442 (+9482.36%) | View |
| 2022-02-10 4:26 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | ELI LILLY & Co LLY | 1,593,997 3.5% | 1,593,997 (New Position) | View |
| 2022-02-09 3:04 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | ARK Investment Management LLC | 5,326,127 11.54% | 849,707 (+18.98%) | View |
| 2022-02-09 10:01 am Sale | 13G | SURFACE ONCOLOGY INC SURF | FMR LLC | 1,729,801 3.749% | -318,520 (-15.55%) | View |
| 2022-02-04 4:26 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | BlackRock Inc. BLK | 2,562,685 5.6% | 2,562,685 (New Position) | View |
| 2022-01-25 11:30 am Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 2,945,453 6.38% | 0 (Unchanged) | View |
| 2021-07-09 12:05 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | ARK Investment Management LLC | 4,476,420 10.31% | 1,934,029 (+76.07%) | View |
| 2021-02-16 4:33 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | ARK Investment Management LLC | 2,542,391 6.25% | 2,542,391 (New Position) | View |
| 2021-02-16 4:10 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | Venrock Healthcare Capital Partners II L.P. | 1,442,895 3.5% | -2,435,000 (-62.79%) | View |
| 2021-02-16 12:16 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 48,558 0.1% | -4,985,303 (-99.04%) | View |
| 2021-02-12 5:08 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | Lilly Ventures Fund I LLC | 3,447,817 8.5% | -36,801 (-1.06%) | View |
| 2021-02-12 1:28 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | New Enterprise Associates 14 L.P. | 0 0% | -3,312,877 (Position Closed) | View |
| 2021-02-11 5:10 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -2,125,650 (Position Closed) | View |
| 2021-02-10 06:33 am Purchase | 13G | SURFACE ONCOLOGY INC SURF | LV Management Group LLC | 56,173 0.1% | 56,173 (New Position) | View |